Abstract
The escalating incidence of skin lesions, coupled with a scarcity of dermatologists and the intricate nature of diagnostic procedures, has resulted in prolonged waiting periods. Consequently, morbidity and mortality rates stemming from untreated cancerous skin lesions have witnessed an upward trend. To address this issue, we propose a skin lesion classification model that leverages the efficient net B7 Convolutional Neural Network (CNN) architecture, enabling early screening of skin lesions based on camera images. The model is trained on a diverse dataset encompassing eight distinct skin lesion classes: Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), Melanoma (MEL), Dysplastic Nevi (DN), Benign Keratosis-Like lesions (BKL), Melanocytic Nevi (NV), and an ‘Other’ class. Through multiple iterations of data preprocessing, as well as comprehensive error analysis, the model achieves a remarkable accuracy rate of 87%.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partially funded by National Research Council Canada Industrial Research Assistance Program, Canada
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1.Human Research Ethics Board Approval for use of skin lesion images obtained from the Alberta Health Services(HREB.CC-20-0484, Investigator: Dr.Joshua N. Wong) 2.National Research Council of Canada, Industrial Research Assistance Program (NRC IRAP) Ethics Approval granted for use of skin lesion, burns and keloid images(commercialization), collected in the provinces of Alberta and Ontario(Co-Investigators:Dr.Collin Hong, Skinopathy; Dr.Joshua Wong, University of Alberta Hospital),NRC IRAP Project Number 980371
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵∥ Co-Senior Authors
Data Availability
All data produced in the present study are available upon meeting patient consent guidelines
